Celldex Therapeutics News - CLDX

Company Name	Stock Ticker Symbol	Market	Type
Celldex Therapeutics Inc	CLDX	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.775	-2.09%	36.245	09:51:14

Open Price	Low Price	High Price	Close Price	Prev Close
36.29	35.86	36.52		37.02

more quote information »

Recent News

Date	Time	Source	Heading
4/25/2024	8:52	IHNW	FeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/17/2024	08:01	GLOBE	Celldex Announces Completion of Enrollment in Phase 2 Study..
3/08/2024	07:00	GLOBE	Celldex Therapeutics to Participate in the Leerink Partners..
3/05/2024	10:30	GLOBE	Celldex Therapeutics to Present at TD Cowen’s 44th Annual..
3/05/2024	10:10	GLOBE	Celldex Therapeutics Announces Closing of Public Offering of..
3/01/2024	16:10	EDGAR2	Form 8-K - Current report
3/01/2024	16:09	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2/29/2024	21:14	GLOBE	Celldex Therapeutics Announces Pricing of Upsized $400..
2/28/2024	16:10	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2/28/2024	16:01	GLOBE	Celldex Therapeutics Announces Proposed Public Offering of..
2/26/2024	08:18	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2/26/2024	07:05	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/26/2024	07:01	EDGAR2	Form 8-K - Current report
2/26/2024	07:01	GLOBE	Celldex Reports Fourth Quarter and Year End 2023 Financial..
2/24/2024	14:05	GLOBE	Celldex Therapeutics Presents Positive 12 Week Results from..
2/15/2024	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/14/2024	16:17	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/14/2024	12:52	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2/14/2024	11:48	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2/14/2024	07:38	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/13/2024	09:41	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2/08/2024	10:11	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/06/2024	16:01	GLOBE	Celldex to Participate in the Guggenheim Healthcare Talks..
2/05/2024	08:01	GLOBE	Celldex Announces Upcoming Presentation of Barzolvolimab..
1/04/2024	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/27/2023	16:15	GLOBE	Celldex Therapeutics to Present at 6th Annual Evercore ISI..
11/20/2023	16:15	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
11/08/2023	17:03	EDGAR2	Form 8-K - Current report
11/08/2023	17:01	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
11/07/2023	23:15	GLOBE	Celldex Therapeutics Announces Pricing of Public Offering of..
11/07/2023	16:01	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
11/07/2023	16:01	GLOBE	Celldex Therapeutics Announces Proposed Public Offering of..
11/06/2023	09:00	EDGAR2	Form 8-K - Current report
11/06/2023	06:30	GLOBE	Celldex Therapeutics Announces Positive Topline Results from..
11/05/2023	15:00	GLOBE	Celldex Therapeutics Presents Positive Data from Prurigo..
11/03/2023	16:01	EDGAR2	Form S-3ASR - Automatic shelf registration statement of..
11/02/2023	16:06	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/2023	16:01	EDGAR2	Form 8-K - Current report
11/02/2023	16:01	GLOBE	Celldex Reports Third Quarter 2023 Financial Results and..
9/26/2023	07:01	GLOBE	Celldex Announces Acceptance of Abstract for Barzolvolimab..
9/25/2023	08:31	GLOBE	Celldex Therapeutics to Present at Cantor Global Healthcare..
8/08/2023	16:06	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/2023	16:01	EDGAR2	Form 8-K - Current report
8/08/2023	16:01	GLOBE	Celldex Reports Second Quarter 2023 Financial Results and..
7/11/2023	08:01	GLOBE	Celldex Announces Completion of Enrollment in Phase 2 Study..
7/06/2023	08:01	GLOBE	Celldex Announces First Patient Dosed in Phase 2 Study of..
6/10/2023	10:45	GLOBE	Celldex Therapeutics Presents Positive Data from..
6/08/2023	16:01	GLOBE	Celldex Therapeutics Announces Upcoming Barzolvolimab..
6/02/2023	08:01	GLOBE	Celldex Therapeutics to Present at Jefferies Healthcare..
5/31/2023	08:01	GLOBE	Celldex Announces First Patient Dosed in Phase 1 Study of..
5/15/2023	08:01	GLOBE	Celldex Therapeutics Presents Positive Preclinical Data from..